HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yuri B Pride Selected Research

ST Elevation Myocardial Infarction

7/2011Association of initial thrombolysis in myocardial infarction flow grade with mortality among patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a National Registry of Myocardial Infarction-5 (NRMI-5) analysis.
9/2010Relation between infarct size in ST-segment elevation myocardial infarction treated successfully by percutaneous coronary intervention and left ventricular ejection fraction three months after the infarct.
11/2009Outcomes among patients with ST-segment-elevation myocardial infarction presenting to interventional hospitals with and without on-site cardiac surgery.
10/2009Outcomes among patients with non-ST-segment elevation myocardial infarction presenting to interventional hospitals with and without on-site cardiac surgery.
8/2009Relation between myocardial infarct size and ventricular tachyarrhythmia among patients with preserved left ventricular ejection fraction following fibrinolytic therapy for ST-segment elevation myocardial infarction.
7/2009Association of Thrombolysis in Myocardial Infarction Myocardial Perfusion Grade with cardiovascular magnetic resonance measures of infarct architecture after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
2/2009Association of TIMI myocardial perfusion grade and ST-segment resolution with cardiovascular magnetic resonance measures of microvascular obstruction and infarct size following ST-segment elevation myocardial infarction.
1/2009Association of non-steroidal anti-inflammatory drugs with outcomes in patients with ST-segment elevation myocardial infarction treated with fibrinolytic therapy: an ExTRACT-TIMI 25 analysis.
12/2008Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006.
10/2008Angiographic perfusion score in patients treated with PCI at late angiography following fibrinolytic administration for ST-segment elevation myocardial infarction is associated with morbidity and mortality at 30 days.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yuri B Pride Research Topics

Disease

18Myocardial Infarction
03/2013 - 01/2008
14ST Elevation Myocardial Infarction
07/2011 - 01/2008
6Acute Coronary Syndrome
09/2012 - 07/2009
6Infarction (Infarctions)
09/2010 - 02/2008
2Hemorrhage
10/2011 - 09/2009
2Myocardial Ischemia (Ischemic Heart Diseases)
10/2011 - 07/2009
2Non-ST Elevated Myocardial Infarction
09/2010 - 10/2009
2Pathologic Constriction (Stenosis)
09/2010 - 08/2007
2Hypertension (High Blood Pressure)
09/2009 - 01/2009
2Ventricular Tachycardia
08/2009 - 02/2008
2Neoplasms (Cancer)
09/2003 - 07/2003
1Necrosis
03/2013
1Chest Pain (Chest Pains)
03/2013
1Unstable Angina
09/2010
1Rupture
08/2010
1Infections
12/2009
1Stroke (Strokes)
09/2009
1Ischemia
07/2009
1Heart Failure
01/2009
1Shock
01/2009
1Ventricular Fibrillation
02/2008
1Hypoglycemia (Reactive Hypoglycemia)
02/2008
1Hyperglycemia
02/2008
1Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria)
12/2006

Drug/Important Bio-Agent (IBA)

7Clopidogrel (Plavix)FDA Link
09/2009 - 01/2008
5N(2)-(3-trifluoromethylphenyl)guanineIBA
11/2011 - 02/2008
3Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
09/2009 - 01/2008
2Biomarkers (Surrogate Marker)IBA
03/2013 - 08/2010
2Prasugrel HydrochlorideFDA Link
08/2010 - 09/2009
2S- (2- chloro- 1,1,2- trifluoroethyl)cysteine (CTFC)IBA
02/2009 - 05/2008
2Fibrinolytic Agents (Antithrombotic Agents)IBA
01/2009 - 10/2008
1Glycoproteins (Glycoprotein)IBA
09/2012
1TroponinIBA
09/2010
1GadoliniumIBA
09/2010
1pexelizumabIBA
01/2010
1Pravastatin (Pravachol)FDA LinkGeneric
12/2009
1omega-Chloroacetophenone (Mace)IBA
12/2009
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2009
1Atorvastatin (Lipitor)FDA Link
12/2009
1Creatine Kinase (Creatine Phosphokinase)IBA
08/2009
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2009
1Enoxaparin (Lovenox)FDA LinkGeneric
01/2009
1Cyclooxygenase 1IBA
01/2009
1Heparin (Liquaemin)FDA LinkGeneric
01/2009
1Blood Glucose (Blood Sugar)IBA
02/2008
1Glucose (Dextrose)FDA LinkGeneric
02/2008
1eculizumabFDA Link
12/2006
1Therapeutic UsesIBA
09/2003
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
09/2003
1((3Z)- N- (3- chlorophenyl)- 3- ((3,5- dimethyl- 4- ((4- methylpiperazin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- N- methyl- 2- oxo- 2,3- dihydro- 1H- indole- 5- sulfonamide)IBA
09/2003
1Phosphotransferases (Kinase)IBA
09/2003
1Proto-Oncogene Proteins c-metIBA
09/2003
1Pharmaceutical PreparationsIBA
07/2003

Therapy/Procedure

13Percutaneous Coronary Intervention
09/2012 - 01/2008
11Therapeutics
10/2011 - 09/2003
6Thrombolytic Therapy
08/2009 - 01/2008
3Stents
10/2011 - 08/2007
2Coronary Artery Bypass (Coronary Artery Bypass Surgery)
09/2010 - 09/2009